Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
NCT06378853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 548
Last updated 2024-04-23
Summary
By evaluating the nutritional status of patients with pancreatic ductal adenocarcinoma (PDAC) admitted to Jinling Hospital, collecting relevant clinical data. we aim to conduct correlation analysis with patient clinical information, such as survival time, hospitalization time, nutritional status, hematological indicators, etc., in order to reveal the prognostic factors for overall survival and postoperative complications of PDAC patients.
Conditions
Interventions
- OTHER
-
no intervention
no intervention
Sponsors & Collaborators
-
Jinling Hospital, China
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2023-12-31
- Completion
- 2024-02-28
Countries
- China
Study Locations
More Related Trials
-
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT06151223 ·Status: RECRUITING
-
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy
NCT03659292 ·Status: UNKNOWN ·Phase: NA
-
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
NCT06122896 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.
NCT05723978 ·Status: COMPLETED
-
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 ·Status: UNKNOWN
-
Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
NCT03498326 ·Status: RECRUITING ·Phase: PHASE2
-
Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy
NCT07329920 ·Status: COMPLETED
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC
NCT04855331 ·Status: RECRUITING ·Phase: NA
-
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
NCT06389760 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
NCT04211948 ·Status: UNKNOWN ·Phase: NA
-
Early Recurrence After Surgery for Pancreatic Cancer
NCT07241676 ·Status: ENROLLING_BY_INVITATION
-
Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching Analysis
NCT06316466 ·Status: RECRUITING
-
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
NCT06638866 ·Status: RECRUITING
-
Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma
NCT02974764 ·Status: COMPLETED
-
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
NCT02723331 ·Status: COMPLETED ·Phase: PHASE2
-
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
NCT06208436 ·Status: RECRUITING
-
Diet and Exercise After Pancreatic Cancer
NCT03187028 ·Status: COMPLETED ·Phase: NA
-
Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma
NCT06478056 ·Status: COMPLETED ·Phase: NA
-
A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
NCT03840460 ·Status: UNKNOWN
-
Personalized Precision Diagnosis and Treatment of Pancreatic Cancer
NCT04373928 ·Status: UNKNOWN ·Phase: NA
-
Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
NCT02023021 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis
NCT06241586 ·Status: COMPLETED
-
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
NCT04025840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.
NCT06397846 ·Status: RECRUITING ·Phase: NA